All filters
Slidesets
Does siRNA Restore Host Control and Could it Lead to Sustained HBsAg Suppression? - Michael J. Sofia, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Discrimination of Integrated vs. cccDNA Derived HBsAg - Chloe Thio, MD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Bepirovirsen in Combination with Peg-IFN and Other Molecules - Stuart Kendrick, MD, PhD, MRCP
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Balance of Response and Adverse Events in Immunotherapy for CHB - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Are We Only Able to Suppress HDV or is Cure in Reach? - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Slidesets
Anti-HBs Monoclonal Antibodes in Nuc-naïve and Combo Therapies - Carey Hwang, MD, PhD
Presented at:
International Workshop on HBV Cure 2023
Videos
New Therapeutic Combination Trials – What Are Their Potential to Achieve a Cure? - Mark Sulkowski
Presented at:
International Workshop on HBV Cure 2022
Videos
What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Development of Assembly Next Generation Core Inhibitors - Grace Wang
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Evidence of T Cell Restoration after siRNA Therapy - Emily Thi
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni
Presented at:
International Workshop on HBV Cure 2022
Slidesets
HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - Morven Cunningham
Presented at:
International Workshop on HBV Cure 2022
Slidesets
What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld
Presented at:
International Workshop on HBV Cure 2022
Videos
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Videos
Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - M. Cunningham
Presented at:
International Workshop on HBV Cure 2022
Videos
Is Therapy-Induced HBs Decline the Same as Naturally Low HBs? - Jordan Feld
Presented at:
International Workshop on HBV Cure 2022
Videos
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022